Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | QPCT | Q16769 | 9/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.41 |
| ▸ | DRD2 | P14416 | 3/20 | 0.40 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.40 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30245411 | 1.00 | QPCT (0.58) | QPCTALDH1A1TSHRSMN1; SMN2NPSR1 | |
| SCHEMBL30245070 | 0.98 | QPCT (0.60) | QPCTALDH1A1TSHRSMN1; SMN2NPSR1 | |
| SCHEMBL30245004 | 0.95 | QPCT (0.59) | QPCTALDH1A1TSHRSMN1; SMN2NPSR1 | |
| SCHEMBL25426289 | 0.95 | QPCT (0.59) | QPCTALDH1A1TSHRSMN1; SMN2NPSR1 | |
| SCHEMBL30245366 | 0.93 | QPCT (0.59) | QPCTALDH1A1TSHRSMN1; SMN2NPSR1 | |
| SCHEMBL25425366 | 0.93 | QPCT (0.59) | QPCTALDH1A1TSHRSMN1; SMN2NPSR1 | |
| SCHEMBL25425574 | 0.93 | QPCT (0.61) | QPCTALDH1A1TSHRSMN1; SMN2NPSR1 | |
| SCHEMBL30244957 | 0.93 | QPCT (0.61) | QPCTALDH1A1TSHRSMN1; SMN2NPSR1 | |
| SCHEMBL25424733 | 0.91 | QPCT (0.55) | QPCTALDH1A1TSHRSMN1; SMN2NPSR1 | |
| SCHEMBL30244832 | 0.91 | QPCT (0.55) | QPCTALDH1A1TSHRSMN1; SMN2NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023018472-A9 | AMINOARYL-INTEGRIN AGONISTS COMPOUNDS | TEXAS HEART INSTITUTE (US) | 2023-07-13 | — | — | WO | disclosed |